Stock Code: 000999 stock abbreviation: China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) No.: 2022-012
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999)
Announcement of the resolution of the second meeting of the board of supervisors in 2022
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) the second meeting of the board of supervisors in 2022 was held by means of communication on the morning of February 15, 2022. The notice of the meeting shall be sent in writing on February 12, 2022. Five supervisors should be present at this meeting and five actually present. The convening and convening procedures of this meeting comply with the relevant provisions of the company law, the articles of association and the rules of procedure of the board of supervisors, and the meeting is legal and effective. The meeting deliberated and passed the following proposals by voting and formed a resolution:
1、 Proposal on the company’s 2021 restricted stock incentive plan (Revised Draft) and its summary
The company’s restricted stock incentive plan for 2021 (Revised Draft) and its abstract are detailed on cninfo.com.cn.
The board of supervisors believes that the contents of the company’s restricted stock incentive plan for 2021 (Revised Draft) and its abstract comply with the company law, the securities law, the measures for the administration of equity incentive of listed companies (CSRC Order No. 126) and the notice on matters related to further improving the equity incentive of listed companies controlled by central enterprises (Guo Zi FA Kao Fen GUI [2019] No. 102) According to the notice on printing and distributing the guidelines for the implementation of equity incentive by listed companies controlled by central enterprises (gzkp [2020] No. 178) and other relevant laws, regulations and normative documents, as well as the provisions of the articles of association, the implementation of this incentive plan will help to further establish and improve the company’s long-term incentive and restraint mechanism and deal with the fierce competition in the pharmaceutical industry, Fully mobilize the enthusiasm of the company’s management and core talents, which is conducive to the sustainable development of listed companies and does not harm the interests of the company and all shareholders.
This proposal must be submitted to the general meeting of shareholders of the company for deliberation.
Voting results: 5 in favor, 0 against and 0 abstention
2、 Proposal on the list of incentive objects first granted by the restricted stock incentive plan in 2021
See cninfo.com.cn for the list of incentive objects first granted under the restricted stock incentive plan in 2021.
The board of supervisors believes that the incentive objects listed in the incentive plan comply with the scope and conditions of incentive objects specified in the management measures, implementation guidelines and other laws and regulations, normative documents and the incentive plan (Revised Draft), and there is no situation that they cannot become incentive objects. Their subject qualification as incentive objects of the incentive plan is legal and effective.
Before convening the general meeting of shareholders, the company shall publicize the names and positions of incentive objects within the company through the company’s website or other channels, and the publicity period shall not be less than 10 days. The board of supervisors will disclose the explanation on the review and publicity of the list of incentive objects five days before the shareholders’ meeting deliberates the restricted stock incentive plan.
Voting results: 5 in favor, 0 against and 0 abstention
It is hereby announced.
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) board of supervisors February 15, 2002
